Page last updated: 2024-11-02

pindolol and Diathesis

pindolol has been researched along with Diathesis in 2 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Research Excerpts

ExcerptRelevanceReference
" At dosage levels similar to arotinolol, both pindolol and labetalol were less effective in preventing cerebral lesions despite lower blood pressure."1.28Prevention of cerebral stroke by arotinolol in salt-loaded SHRSP. ( Hara, Y; Maniwa, T; Miyagishi, A; Noguchi, T, 1991)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyagishi, A1
Maniwa, T1
Noguchi, T1
Hara, Y1
Yamashita, K1
Shigematsu, K1
Maeda, T1
Ishida, Y1
Niwa, M1
Ozaki, M1

Other Studies

2 other studies available for pindolol and Diathesis

ArticleYear
Prevention of cerebral stroke by arotinolol in salt-loaded SHRSP.
    Clinical and experimental hypertension. Part A, Theory and practice, 1991, Volume: 13, Issue:5

    Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Brain; Cerebrovascular Disorders; Disease Susc

1991
[Antihypertensive effect of bopindolol on stroke-prone spontaneously hypertensive rats (SHRSP)].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1989, Volume: 93, Issue:1

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure;

1989